• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1,3 - 二烷基黄嘌呤衍生物对大鼠A3腺苷受体的构效关系

Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.

作者信息

Kim H O, Ji X D, Melman N, Olah M E, Stiles G L, Jacobson K A

机构信息

Molecular Recognition Section, National Institute of Diabetes, and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.

出版信息

J Med Chem. 1994 Sep 30;37(20):3373-82. doi: 10.1021/jm00046a022.

DOI:10.1021/jm00046a022
PMID:7932565
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3471218/
Abstract

1,3-Dialkylxanthine analogues containing carboxylic acid and other charged groups on 8-position substituents were synthesized. These derivatives were examined for affinity in radioligand binding assays at rat brain A3 adenosine receptors stably expressed in CHO cells using the new radioligand [125I]AB-MECA (N6-(4-amino-3-iodobenzyl)adenosine-5'-N-methyluronamide), and at rat brain A1 and A2a receptors using [3H]PIA and [3H]CGS 21680, respectively. A synthetic strategy for introducing multiple carboxylate groups at the 8-position using iminodiacetic acid derivatives was explored. The presence of a sulfonate, a carboxylate, or multiple carboxylate groups did not result in a significant enhancement of affinity at rat A3 receptors, although as previously observed an anionic group tended to diminish potency at A1 and A2a receptors. The rat A3 receptor affinity was not highly dependent on the distance of a carboxylate group from the xanthine pharmacophore. 2-Thio vs 2-oxo substitution favored A3 potency, and 8-alkyl vs 8-aryl substitution favored A3 selectivity, although few derivatives were truly selective for rat A3 receptors. 1,3-Dimethyl-8-(3-carboxypropyl)-2-thioxanthine was 7-fold selective for A3 vs A2a receptors. 1,3,7-Trimethyl-8-(trans-2-carboxyvinyl)xanthine was somewhat selective for A3 vs A1 receptors. For 8-arylxanthines affinity at A3 receptors was enhanced by 1,3-dialkyl substituents, in the order dibutyl > dipropyl > diallyl.

摘要

合成了在8位取代基上含有羧酸和其他带电基团的1,3 - 二烷基黄嘌呤类似物。使用新的放射性配体[125I]AB - MECA(N6 - (4 - 氨基 - 3 - 碘苄基)腺苷 - 5'-N - 甲基脲酰胺),在稳定表达于CHO细胞中的大鼠脑A3腺苷受体的放射性配体结合试验中检测了这些衍生物的亲和力;分别使用[3H]PIA和[3H]CGS 21680,在大鼠脑A1和A2a受体中检测了它们的亲和力。探索了一种使用亚氨基二乙酸衍生物在8位引入多个羧酸根基团的合成策略。磺酸根、羧酸根或多个羧酸根基团的存在并未导致大鼠A3受体亲和力的显著增强,尽管如先前观察到的,阴离子基团往往会降低A1和A2a受体的活性。大鼠A3受体亲和力并不高度依赖于羧酸根基团与黄嘌呤药效基团的距离。2 - 硫代取代与2 - 氧代取代相比有利于A3活性,8 - 烷基取代与8 - 芳基取代相比有利于A3选择性,尽管很少有衍生物对大鼠A3受体具有真正的选择性。1,3 - 二甲基 - 8 - (3 - 羧丙基)-2 - 硫代黄嘌呤对A3受体与A2a受体的选择性为7倍。1,3,7 - 三甲基 - 8 - (反式 - 2 - 羧乙烯基)黄嘌呤对A3受体与A1受体略有选择性。对于8 - 芳基黄嘌呤,1,3 - 二烷基取代基按二丁基>二丙基>二烯丙基的顺序增强了其对A3受体的亲和力。

相似文献

1
Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors.1,3 - 二烷基黄嘌呤衍生物对大鼠A3腺苷受体的构效关系
J Med Chem. 1994 Sep 30;37(20):3373-82. doi: 10.1021/jm00046a022.
2
Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives.大鼠A3腺苷受体的选择性配体:1,3 - 二烷基黄嘌呤7 - 核糖苷衍生物的构效关系
J Med Chem. 1994 Nov 11;37(23):4020-30. doi: 10.1021/jm00049a021.
3
Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors.9-烷基腺嘌呤及核糖修饰的腺苷衍生物在大鼠A3腺苷受体上的构效关系
J Med Chem. 1995 May 12;38(10):1720-35. doi: 10.1021/jm00010a017.
4
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.N6-苄基腺苷-5'-脲酰胺的2-取代增强了对A3腺苷受体的选择性。
J Med Chem. 1994 Oct 14;37(21):3614-21. doi: 10.1021/jm00047a018.
5
Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.1,4-二氢吡啶和吡啶衍生物与腺苷受体的相互作用:对A3受体的选择性
J Med Chem. 1996 Jul 19;39(15):2980-9. doi: 10.1021/jm9600205.
6
Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.人腺苷受体亚型的比较药理学——CHO细胞中稳定转染受体的特性研究
Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):1-9. doi: 10.1007/pl00005131.
7
Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists.黄酮类衍生物作为A3腺苷受体拮抗剂的合成及生物活性
J Med Chem. 1996 Jun 7;39(12):2293-301. doi: 10.1021/jm950923i.
8
Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists.N6-苄基腺苷-5'-脲酰胺作为A3选择性腺苷激动剂的构效关系
J Med Chem. 1994 Mar 4;37(5):636-46. doi: 10.1021/jm00031a014.
9
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.3,5-二酰基-2,4-二烷基吡啶衍生物作为选择性A3腺苷受体拮抗剂的构效关系及分子模拟
J Med Chem. 1998 Aug 13;41(17):3186-201. doi: 10.1021/jm980093j.
10
Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists.3,5-二酰基-2,4-二烷基吡啶衍生物作为选择性A3腺苷受体拮抗剂的合成、比较分子场分析及受体对接
J Med Chem. 1999 Feb 25;42(4):706-21. doi: 10.1021/jm980550w.

引用本文的文献

1
1,3-Dialkylxanthine Derivatives Having High Potency as Antagonists at Human A Adenosine Receptors.作为人 A 型腺苷受体拮抗剂具有高效能的 1,3 - 二烷基黄嘌呤衍生物。
Drug Dev Res. 1999 May;47(1):45-53. doi: 10.1002/(sici)1098-2299(199905)47:1<45::aid-ddr6>3.0.co;2-u.
2
Recent Developments in Selective Agonists and Antagonists Acting at Purine and Pyrimidine Receptors.作用于嘌呤和嘧啶受体的选择性激动剂和拮抗剂的最新进展。
Drug Dev Res. 1996 Nov-Dec;39(3-4):289-300. doi: 10.1002/(sici)1098-2299(199611/12)39:3/4<289::aid-ddr8>3.0.co;2-n.
3
A Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy.腺嘌呤受体作为炎症的调节剂:从药物化学到治疗。
Med Res Rev. 2018 Jul;38(4):1031-1072. doi: 10.1002/med.21456. Epub 2017 Jul 6.
4
A-adenosine receptors: design of selective ligands and therapeutic prospects.A 型腺苷受体:选择性配体的设计与治疗前景
Drugs Future. 1995 Jul;20(7):689-699. doi: 10.1358/dof.1995.020.07.531583.
5
Activation and Desensitization of Rat A-Adenosine Receptors by Selective Adenosine Derivatives and Xanthine-7-Ribosides.选择性腺苷衍生物和黄嘌呤-7-核糖苷对大鼠A1-腺苷受体的激活与脱敏作用
Drug Dev Res. 1998 Jun 1;44(2-3):97-105. doi: 10.1002/(SICI)1098-2299(199806/07)44:2/3<97::AID-DDR7>3.0.CO;2-5.
6
Xanthines as adenosine receptor antagonists.作为腺苷受体拮抗剂的黄嘌呤类药物。
Handb Exp Pharmacol. 2011(200):151-99. doi: 10.1007/978-3-642-13443-2_6.
7
[3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors.[3H]MRS 1754,一种A(2B) 腺苷受体的选择性拮抗剂放射性配体。
Biochem Pharmacol. 2001 Mar 15;61(6):657-63. doi: 10.1016/s0006-2952(01)00531-7.
8
Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.一种8-苯基黄嘌呤羧酸同系物的酰苯胺衍生物是强效且选择性的人A(2B)腺苷受体拮抗剂。
J Med Chem. 2000 Mar 23;43(6):1165-72. doi: 10.1021/jm990421v.
9
Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.三唑并喹唑啉腺苷拮抗剂(CGS15943)的衍生物对人A3受体亚型具有选择性。
J Med Chem. 1996 Oct 11;39(21):4142-8. doi: 10.1021/jm960482i.
10
Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors.1,4-二氢吡啶和吡啶衍生物与腺苷受体的相互作用:对A3受体的选择性
J Med Chem. 1996 Jul 19;39(15):2980-9. doi: 10.1021/jm9600205.

本文引用的文献

1
Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.8-苯乙烯基黄嘌呤作为A2选择性腺苷拮抗剂的构效关系
J Med Chem. 1993 May 14;36(10):1333-42. doi: 10.1021/jm00062a005.
2
8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo.8-(3-氯苯乙烯基)咖啡因(CSC)在体外和体内均为选择性A2-腺苷拮抗剂。
FEBS Lett. 1993 May 24;323(1-2):141-4. doi: 10.1016/0014-5793(93)81466-d.
3
Adenosine A3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat.腺苷A3受体介导去脑大鼠在血管紧张素II维持的循环中的低血压。
Br J Pharmacol. 1993 May;109(1):3-5. doi: 10.1111/j.1476-5381.1993.tb13522.x.
4
Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors.三氟甲基及其他取代基对黄嘌呤类化合物在腺苷受体上活性的影响。
J Med Chem. 1993 Sep 3;36(18):2639-44. doi: 10.1021/jm00070a007.
5
Molecular cloning and functional expression of a sheep A3 adenosine receptor with widespread tissue distribution.具有广泛组织分布的绵羊A3腺苷受体的分子克隆与功能表达
Mol Pharmacol. 1993 Sep;44(3):524-32.
6
The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells.A3 腺苷受体是唯一能促进肥大细胞释放过敏介质的腺苷受体。
J Biol Chem. 1993 Aug 15;268(23):16887-90.
7
A role for central A3-adenosine receptors. Mediation of behavioral depressant effects.中枢A3-腺苷受体的作用。行为抑制作用的介导。
FEBS Lett. 1993 Dec 20;336(1):57-60. doi: 10.1016/0014-5793(93)81608-3.
8
Photoisomerization of a potent and selective adenosine A2 antagonist, (E)-1,3-Dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine.一种强效且选择性的腺苷A2拮抗剂(E)-1,3-二丙基-8-(3,4-二甲氧基苯乙烯基)-7-甲基黄嘌呤的光异构化作用
J Med Chem. 1993 Nov 12;36(23):3731-3. doi: 10.1021/jm00075a031.
9
Molecular cloning and characterization of the human A3 adenosine receptor.人类A3腺苷受体的分子克隆与特性分析
Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10365-9. doi: 10.1073/pnas.90.21.10365.
10
125I-4-aminobenzyl-5'-N-methylcarboxamidoadenosine, a high affinity radioligand for the rat A3 adenosine receptor.125I - 4 - 氨基苄基 - 5'-N - 甲基羧酰胺腺苷,一种对大鼠A3腺苷受体具有高亲和力的放射性配体。
Mol Pharmacol. 1994 May;45(5):978-82.